Rockwell Medical to Showcase Innovations at ASN Kidney Week 2025

Rockwell Medical to Showcase Comprehensive Hemodialysis Concentrates Portfolio at ASN Kidney Week 2025 WIXOM, Mich. — October 29, 2025 — Rockwell Medical, Inc. (the “Company”) (Nasdaq: RMTI), a global healthcare company specializing in the development, manufacture, commercialization, and distribution of…

Read MoreRockwell Medical to Showcase Innovations at ASN Kidney Week 2025

Genentech Reports Positive Phase III Results for Gazyva in Youth Nephrotic Syndrome

Genentech Reports Positive Phase III Results for Gazyva in Children and Young Adults With Idiopathic Nephrotic Syndrome Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced statistically significant and clinically meaningful findings from its Phase…

Read MoreGenentech Reports Positive Phase III Results for Gazyva in Youth Nephrotic Syndrome